You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bococizumab

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dyslipidemia, Cardiovascular Disease Trial in San Francisco (Bococizumab, Placebo)

Terminated
Has Results
  • Dyslipidemia
  • Cardiovascular Disease
  • Bococizumab
  • Placebo
  • San Francisco, California
  • +2 more
Jun 17, 2019

Hypercholesterolemia Trial in United States (Bococizumab (PF-04950615; RN316))

Completed
Has Results
  • Hypercholesterolemia
  • Bococizumab (PF-04950615; RN316)
  • Anaheim, California
  • +5 more
Feb 14, 2019

Hypercholesterolemia Trial in Japan (Bococizumab (PF-04950615;RN316), Placebo, Ezetimibe)

Completed
Has Results
  • Hypercholesterolemia
  • Bococizumab (PF-04950615;RN316)
  • +2 more
  • Maebashi, Gunma, Japan
  • +8 more
Sep 4, 2018

Primary Hyperlipidemia or Mixed Dyslipidemia Trial in Beijing (Bococizumab, Placebo)

Withdrawn
  • Primary Hyperlipidemia or Mixed Dyslipidemia
  • Bococizumab
  • Placebo
  • Beijing, Beijing, China
    Beijing Anzhen Hospital, Capital Medical University
Nov 29, 2017

Hyperlipidemia Trial in United States (Bococizumab 150mg, Bococizumab 75mg, Bococizumab 150mg )

Completed
Has Results
  • Hyperlipidemia
  • Bococizumab 150mg
  • +3 more
  • Chandler, Arizona
  • +29 more
Nov 20, 2017

Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)

Terminated
Has Results
  • Cardiovascular Disease
  • bococizumab (PF-04950615)
  • Placebo
  • Athens, Alabama
  • +1595 more
Apr 18, 2019

Hyperlipidemia Trial in Canada, United States (Bococizumab (PF-04950615;RN316), Atorvastatin, Placebo for Bococizumab

Completed
Has Results
  • Hyperlipidemia
  • Bococizumab (PF-04950615;RN316)
  • +3 more
  • Denver, Colorado
  • +39 more
Nov 17, 2017

Hyperlipidemia Trial in Worldwide (Bococizumab (PF-04950615; RN316), Placebo)

Completed
Has Results
  • Hyperlipidemia
  • Bococizumab (PF-04950615; RN316)
  • Placebo
  • Alexander City, Alabama
  • +222 more
Jul 2, 2018

Hyperlipidemia Trial in Worldwide (Bococizumab (PF-04950615; RN316), Placebo)

Completed
Has Results
  • Hyperlipidemia
  • Bococizumab (PF-04950615; RN316)
  • Placebo
  • Athens, Alabama
  • +248 more
Jul 2, 2018

Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)

Terminated
Has Results
  • Cardiovascular Disease
  • bococizumab (PF-04950615)
  • Placebo
  • Athens, Alabama
  • +1745 more
Jun 14, 2018

Healthy, Hypercholesterolemia Trial in Brussels (Cohort 1: bococizumab 150 mg + rHuPH20, Cohort 2: bococizumab 300 mg, Cohort 3:

Terminated
  • Healthy
  • Hypercholesterolemia
  • Cohort 1: bococizumab 150 mg + rHuPH20
  • +4 more
  • Brussels, Belgium
    Pfizer Clinical Research Unit
Oct 19, 2016

Hypercholesterolemia Trial in United States (PF-05335810 Dose A, PF-05335810 Dose B, Placebo)

Completed
  • Hypercholesterolemia
  • PF-05335810 Dose A
  • +7 more
  • New Haven, Connecticut
  • +6 more
Nov 30, 2018

Heterozygous Familial Hypercholesterolemia Trial in Worldwide (Bococizumab (PF-04950615;RN316), Placebo)

Completed
Has Results
  • Heterozygous Familial Hypercholesterolemia
  • Bococizumab (PF-04950615;RN316)
  • Placebo
  • Los Angeles, California
  • +87 more
May 31, 2017

Hyperlipidemia Trial in Worldwide (Bococizumab (PF-04950615;RN316), Placebo)

Completed
Has Results
  • Hyperlipidemia
  • Bococizumab (PF-04950615;RN316)
  • Placebo
  • Birmingham, Alabama
  • +102 more
Apr 6, 2017

Healthy Trial in United States (bococizumab PFS:Pfizer, bococizumab PFS: BIP, bococizumab PFP)

Completed
  • Healthy
  • bococizumab PFS:Pfizer
  • +2 more
  • Hollywood, Florida
  • +4 more
Mar 7, 2016

Hypercholesterolemia, Dyslipidemias, Hyperlipidemias Trial in United States (PF-04950615 (RN316))

Completed
Has Results
  • Hypercholesterolemia
  • +4 more
  • PF-04950615 (RN316)
  • Chula Vista, California
  • +6 more
Oct 6, 2017

Hypercholesterolemia, Dyslipidemia Trial in United States (PF-04950615 (RN316))

Completed
Has Results
  • Hypercholesterolemia
  • Dyslipidemia
  • PF-04950615 (RN316)
  • Culver City, California
  • +8 more
Aug 8, 2018

Hypercholesterolemia, Dyslipidemia Trial in Canada, United States (Placebo, PF-04950615 (RN316))

Completed
Has Results
  • Hypercholesterolemia
  • Dyslipidemia
  • Placebo
  • PF-04950615 (RN316)
  • Birmingham, Alabama
  • +34 more
Oct 4, 2017

Hypercholesterolemia, Dyslipidemia Trial in Peoria, Phoenix, Overland Park (4 mg/kg, 0.5 mg/kg)

Completed
Has Results
  • Hypercholesterolemia
  • Dyslipidemia
  • 4 mg/kg
  • 0.5 mg/kg
  • Peoria, Arizona
  • +4 more
Jan 31, 2018

Hypercholesterolemia, Dyslipidemia Trial in Canada, United States (Placebo, Statin, PF-04950615 (RN316))

Completed
Has Results
  • Hypercholesterolemia
  • Dyslipidemia
  • Placebo
  • +3 more
  • Tustin, California
  • +43 more
Sep 11, 2017

Hypercholesterolemia Trial in United States (PBO, 200mg PF-04950615 (RN316), 300mg PF-04950615 (RN316))

Completed
Has Results
  • Hypercholesterolemia
  • Birmingham, Alabama
  • +73 more
Oct 27, 2017

Healthy Trial in Phoenix, Miami Gardens (RN316)

Completed
  • Healthy
  • RN316
  • Phoenix, Arizona
  • +1 more
Jul 2, 2012